PrakashAmbadyMD

Neurology • Portland, OR

Neurooncology

Physician

Join to view full profile

Dr. Ambady is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ambady's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Mercy Catholic Medical Cen
Portland, OR 97239
Phone+1 215-688-7448

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 2009 - 2012
Mercy Catholic Medical CenterResidency, Internal Medicine, 2007 - 2009
OtherClass of 2003

Certifications & Licensure

OR State Medical License 2014 - 2025
MD State Medical License 2012 - 2014
PA State Medical License 2007 - 2012
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response Start of enrollment: 2016 Jul 12
Terminated
Phase 2
Roles: Contact, Principal Investigator
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
RECRUITING
PHASE2
Roles: Contact, Principal Investigator
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
RECRUITING
PHASE3
Roles: Contact

Publications & Presentations

PubMed

2 citations
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu
Journal of Clinical Oncology. 2025-02-20
1 citations
Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI.
Doonyaporn Wongsawaeng, Daniel Schwartz, Xin Li, Leslie L Muldoon, Jared Stoller
The Neuroradiology Journal. 2024-08-01
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes.
Jared Stoller, Cymon N Kersch, Leslie L Muldoon, Prakash Ambady, Christina A Harrington
Neuro-Oncology Advances. 2023-11-08